Immune microenvironment modulation following neoadjuvant therapy for oesophageal adenocarcinoma: a translational analysis of the DEBIOC clinical trial.
Scanlon E, Lavery A, Albraikat M, Stevenson L, Kennedy C, Byrne R, Walker A, Mullan-Young B, McManus DT, Virdee PS, Elhussein L, Turbitt J, Collinson D, Miedzybrodzka Z, Van Schaeybroeck S, McQuaid S, James JA, Craig SG, Blayney JK, Petty RD, Harkin DP, Kennedy RD, Eatock MM, Middleton MR, Thomas A, Turkington RC.
Scanlon E, et al. Among authors: kennedy rd.
ESMO Open. 2024 Nov;9(11):103930. doi: 10.1016/j.esmoop.2024.103930. Epub 2024 Oct 11.
ESMO Open. 2024.
PMID: 39395265
Free article.